Chained lightning: Part III - Emerging technology, novel therapeutic strategies, and new energy modalities for radiosurgery

Neurosurgery

Volumn 61, Issue 6, 2007, Pages 1111-1129

  Hoh, Daniel J ^a   Liu, Charles Y ^a   Chen, Joseph C T ^b   Pagnini, Paul G ^a   Yu, Cheng ^a   Wang, Michael Y ^c   Apuzzo, Michael L J ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b KAISER PERMANENTE   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Medical technology; Minimally invasive surgery; Radiation oncology; Radiation physics; Radiosurgery; Radiotherapy; Stereotactic neurosurgery

Indexed keywords

AMINOLEVULINIC ACID METHYL ESTER; CARBOGEN; CYCLOOXYGENASE 2 INHIBITOR; DNA TOPOISOMERASE INHIBITOR; EFAPROXIRAL; ETANIDAZOLE; FLOXURIDINE; FLUDARABINE; FLUORODEOXYGLUCOSE F 18; FLUOROPYRIMIDINE DERIVATIVE; FLUOROURACIL; GALLIUM 68; HEMATOPORPHYRIN DERIVATIVE; HYDROXYUREA; METHIONINE C 11; MISONIDAZOLE; MONOCLONAL ANTIBODY; NANOPARTICLE; NANOSHELL; NIMORAZOLE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; PHOTOSENSITIZING AGENT; PLATINUM DERIVATIVE; RADIOLIGAND; RADIOSENSITIZING AGENT; TAXANE DERIVATIVE; TEMOZOLOMIDE; THYMIDINE DERIVATIVE; TIRAPAZAMINE; UNINDEXED DRUG;

ALTERNATIVE ENERGY; CANCER DIAGNOSIS; CANCER LOCALIZATION; COMPUTER ASSISTED RADIOTHERAPY; DRUG MECHANISM; ELECTRON; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; IMAGING SYSTEM; LASER; MEDICAL TECHNOLOGY; NANOPROBE; NEUROSURGERY; PRIORITY JOURNAL; RADIATION BEAM; RADIATION DOSE FRACTIONATION; RADIATION ENERGY; RADIATION INJURY; RADIOSURGERY; REVIEW;

BRAIN DISEASES; ENERGY TRANSFER; HUMANS; RADIOSURGERY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED;

EID: 37649013752     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.neu.0000306089.22894.4e     Document Type: Review

References (112)

1. Apfel RE: Acoustic cavitation: Apossible consequence of biomedical uses of ultrasound. Br J Cancer Suppl 5:140-146, 1982.
2. Rabin O, Manuel Perez JM, Grimm J, Wojtkiewicz G, Weissleder R: An x-ray computed tomography imaging agent based on long-circulation bismuth sulphide nanoparticles. Nat Mater 5:118-122, 2006.
3. Benson RC: Laser photodynamic therapy for bladder cancer. Mayo Clin Proc 61:859-864, 1986.
4. Bergström M, Collins VP, Ehrin E, Ericson K, Eriksson L, Greitz T, Halldin C, von Holst H, Långström B, Lilja A, Lundquist H, Nagren K: Discrepancies in brain tumor extent as shown by computed tomography and positron emission tomography using [68Ga]EDTA, [11C]glucose, and [11C]methionine. J Comput Assist Tomogr 7:1062-1066, 1983.
5. Bergstrom M, Muhr C, Lundberg PO, Langstrom B: PET as a tool in the clinical evaluation of pituitary adenomas. J Nucl Med 32:610-615, 1991.
6. Brancaleon L, Moseley H: Laser and non-laser light sources for photodynamic therapy. Lasers Med Sci 17:173-186, 2002.
7. Brown JM, Wilson WR: Exploiting tumor hypoxia in cancer treatment. Nat Rev Cancer 4:437-447, 2004.
8. Bush NL, Rivens I, ter Haar GR, Bamber JC: Acoustic properties of lesions generated with an ultrasound therapy system. Ultrasound Med Biol 19: 789-801, 1993.
9. Cairnduff F, Stringer MR, Hudson EJ, Ash DV, Brown SB: Superficial photodynamic therapy with topical 5-aminolevulinic acid for superficial primary and secondary skin cancer. Br J Cancer 69:605-608, 1994.
10. Chang SD, Martin DP, Lee E, Adler JR: Stereotactic radiosurgery and hypofractionated stereotactic radiotherapy for residual or recurrent cranial base and cervical chordomas. Neurosurg Focus 10:1-7, 2001.
11. Chapelon JY, Ribault M, Vernier F, Souchon R, Geleta A: Treatment of localized prostate cancer with transrectal high intensity focused ultrasound. Eur J Ultrasound 9:31-38, 1999.
12. Chen AY, Choy H, Rothenberg ML: DNA topoisomerase I-targeting drugs as radiation sensitizers. Oncology (Williston Park) 5:39-46, 1999.
13. Choy H, Milas L: Enhancing radiotherapy with cyclooxygenase-2 enzyme inhibitors: A rational advance? J Natl Cancer Inst 95:1440-1452, 2003.
14. Clement GT: Perspectives in clinical uses of high-intensity focused ultrasound. Ultrasonics 42:1087-1093, 2004.
15. Clement GT, White PJ, Klin RL, McDannold N, Hynynen K: Amagnetic resonance imaging-compatible, large-scale array for trans-skull ultrasound surgery and therapy. J Ultrasound Med 24:1117-1125, 2005.
16. Clement GT, Hynynen K: A non-invasive method for focusing ultrasound through the human skull. Phys Med Biol 47:1219-1236, 2002.
17. Clement GT, Sun J, Giesecke T, Hynynen K: A hemisphere array for noninvasive ultrasound brain therapy and surgery. Phys Med Biol 45:3707-3719, 2000.
18. Clement GT, White J, Hynynen K: Investigation of a large area phased array for focused ultrasound surgery through the skull. Phys Med Biol 45:1071-1083, 2000.
19. Combs SE, Thilmann C, Debus J, Schulz-Ertner D: Local radiotherapeutic management of ependymomas with fractionated stereotactic radiotherapy (FSRT). BMC Cancer 6:222, 2006.
20. Cortese DA, Edell ES, Kinsey JH: Photodynamic therapy for early stage squamous cell carcinoma of the lung. Mayo Clin Proc 72:595-602, 1997.
21. Das IJ, Downes MB, Corn BW, Curran WJ, Werner-Wasik M, Andrews DW: Characteristics of a dedicated linear accelerator-based stereotactic radiosurgery-radiotherapy unit. Radiother Oncol 38:61-68, 1996
22. De Witte O, Levivier M, Violon P, Brotchi J, Goldman S: Quantitative imaging study of extent of surgical resection and prognosis of malignant astrocytomas. Neurosurgery 43:398-399, 1998.
23. Denny BJ, Wheelhouse RT, Stevens MF, Tsang LL, Slack JA: NMR and molecular modeling investigation of the mechanism of activation of the antitumor drug temozolomide and its interaction with DNA. Biochemistry 33:9045-9051, 1994.
24. Diamond I, Granelli SG, McDonagh AF, Nielson S, Wison CB, Jaenicker R: Photodynamic therapy of malignant tumours. Lancet 2:1175-1177, 1972.
25. Dilmanian FA, Morris GM, Zhong N, Bacarian T, Hainfeld JF, Kalef-Ezra J, Brewington LJ, Tammam J, Rosen EM: Murine EMT-6 carcinoma: High therapeutic efficacy of microbeam radiation therapy. Radiat Res 159:632-641, 2003.
26. Dilmanian FA, Qu Y, Liu S, Cool CD, Gilbert J, Hainfeld JF, Kruse CA, Laterra J, Lenihan D, Nawrocky MM, Pappas G, Sze CI, Yuasa T, Zhong N, Zhong Z, McDonald JW: X-ray microbeams: Tumor therapy and central nervous system research. Nucl Instrum Methods Phys Res A 548:30-37, 2005.
27. Dilmanian FA, Zhong Z, Bacarian T, Benveniste H, Romanelli P, Wang R, Welwart J, Yuasa T, Rosen EM, Anschel DJ: Interlaced x-ray microplanar beams: A radiosurgery approach with clinical potential. Proc Natl Acad Sci U S A 103:9709-9714, 2006.
28. Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M, Moan J, Peng Q: Photodynamic therapy. J Natl Cancer Inst 90:889-905, 1998.
29. Eastman A: The formation, isolation and characterization of DNA adducts produced by anticancer platinum complexes. Pharmacol Ther 34:155-166, 1987.
30. Edwards G, Logan R, Copeland M, Reinisch L, Davidson J, Johnson JB, Maciunas RJ, Mendenhall M, Ossoff R, Tribble J, Werkhaven J, O'Day D: Tissue ablation by a free-electron laser tuned to the amide II band. Nature 371:416-419, 1994.
31. El-Sayed IH, Huang X, El-Sayed MA: Selective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles. Cancer Lett 239:129-135, 2006.
32. Ericson K, Kihlström L, Mogard J, Karlsson B, Lindquist C, Widén L, Collins VP, Stone-Elander S: Positron emission tomography using 18F-fluorodeoxyglucose in patients with stereotactically irradiated brain metastases. Stereoact Funct Neurosurg 66 [Suppl 1]:214-224, 1996.
33. Ernst-Stecken A, Ganslandt O, Lambrecht U, Sauer R, Grabenbauer G: Survival and quality of life after hypofractionated stereotactic radiotherapy for recurrent malignant glioma. J Neurooncol 81:287-294, 2007.
34. Flynn HG: Generation of transient cavities in liquids by microsecond pulses of ultrasound. J Acoust Soc Am 72:1926-1932, 1982.
35. Fortina P, Kricka LJ, Surrey S, Grodzinski P: Nanobiotechnology: The promise and reality of new approaches to molecular recognition. Trends Biotechnol 23:168-173, 2005.
36. Foster RS, Bihrle R, Sanghvi NT, Fry FJ, Donohue JP: High intensity focused ultrasound in the treatment of prostate disease. Eur Urol 23 [Suppl 1]:29-33, 1993.
37. Fry FJ: Precision high intensity focusing ultrasonic machines for surgery. Am J Phys Med 37:152-156, 1958.
38. Fry FJ, Barger JE: Acoustical properties of the human skull. J Acoust Soc Am 63:1576-1590, 1978.
39. Fry WJ, Fry FJ: Fundamental neurological research and human neurosurgery using intense ultrasound. IRE Trans Med Electron 7:166-181, 1960.
40. Fry WJ, Meyers R: Ultrasonic method of modifying brain structures. Confin Neurol 22:315-327, 1962.
41. Grosu AL, Lachner R, Wiedenmann N, Stärk S, Thamm R, Kneschaurek P, Schwaiger M, Molls M, Weber WA: Validation of a method for automatic image fusion (BrainLAB System) of CT Data and 11C-methionine-PET data for stereotactic radiotherapy using a LINAC: First clinical experience. Int J Radiat Oncol Biol Phys 56:1450-1463, 2003.
42. Harari PM: Epidermal growth factor receptor inhibition strategies in oncology. Endocr Relat Cancer 11:689-708, 2004.
43. Henry TR, Frey KA, Sackellares JC, Gilman S, Koeppe RA, Brunberg JA, Ross DA, Berent S, Young AB, Kuhl DE: In vivo cerebral metabolism and central benzodiazepine-receptor binding in temporal lobe epilepsy. Neurology 43:1998-2006, 1993.
44. Hirsch LR, Stafford RJ, Bankson JA, Sershen SR, Rivera B, Price RE, Hazle JD, Halas NH, West JL: Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc Natl Acad Sci U S A 100:13549-13554, 2003.
45. Hisazumi H, Misaki T, Miyoshi N: Photoradiation therapy of bladder tumors. J Urol 130:685-687, 1983.
46. Hoh DJ, Liu CY, Chen JC, Pagnini PG, Yu C, Wang MY, Apuzzo MLJ: Chained lightning, part II: Neurosurgical principles, radiosurgical technology, and the manipulation of energy beam delivery. Neurosurgery 61:433-446, 2007.
47. Hoh DJ, Liu CY, Pagnini PG, Yu C, Wang MY, Apuzzo ML: Chained lightning, part 1: Exploitation of energy and radiobiologic principles for therapeutic purpose. Neurosurgery 61:14-28, 2007.
48. Hsi RA, Rosenthal DI, Glatstein E: Photodynamic therapy in the treatment of cancer. Current state of the art. Drugs 57:725-734, 1999.
49. Huang P, Chubb S, Hertel LW, Grindey GB, Plunkett W: Action of 2,′2′-difluorodeoxycytidine on DNA synthesis. Cancer Res 51:6110-6117, 1991.
50. Huang SM, Harari PM: Modulation of radiation response after epidermal growth factor receptor blockade in squamous cell carcinomas: Inhibition of damage repair, cell cycle kinetics, and tumor angiogenesis. Clin Cancer Res 6:2166-2174, 2000.
51. Hynynen K, Jolesz FA: Demonstration of potential noninvasive ultrasound brain therapy through an intact skull. Ultrasound Med Biol 24:275-283, 1998.
52. Hynynen K, Vykhodtseva NI, Chung AH, Sorrentino V, Colucci V, Jolesz FA: Thermal effects of focused ultrasound on the brain: Determination with MR imaging. Radiology 204:247-253, 1997.
53. Kaanders JH, Bussink J, van der Kogel AJ: Clinical studies of hypoxia modification in radiotherapy. Semin Radiat Oncol 14:233-240, 2004.
54. Kalapurakal JA, Silverman CL, Akhtar N, Andrews DW, Downes B, Thomas PRM: Improved trigeminal and facial nerve tolerance following fractionated stereotactic radiotherapy for large acoustic neuromas. Br J Radiol 72:1202-1207, 1999.
55. Kam NW, O'Connell M, Wisdom JA, Dai H: Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction. Proc Natl Acad Sci U S A 102:11600-11605, 2005.
56. Koo YE, Reddy GR, Bhojani M, Schneider R, Philbert MA, Rehemtulla A, Ross BD, Kopelman R: Brain cancer diagnosis and therapy with nanoplatforms. Adv Drug Deliv Rev 58:1556-1577, 2006.
57. Kumagai M, Imai Y, Nakamura T, Yamasaki Y, Sekino M, Ueno S, Hanaoka K, Kikuchi K, Nagano T, Kaneko E, Shimokado K, Kataoka K: Iron hydroxide nanoparticles coated with poly(ethylene glycol)-poly(aspartic acid) block copolymer as novel magnetic resonance contrast agents for in vivo cancer imaging. Colloids Surf B Biointerfaces 56:174-181, 2007.
58. Laissue JA, Geiser G, Spanne PO, Dilmanian FA, Gebbers JO, Geiser M, Wu XY, Makar MS, Micca PL, Nawrocky MN, Joel DD, Slatkin DN: Neuropathology of ablation of rat gliosarcomas and contiguous brain tissues using a microplanar beam of synchrotron-wiggler-generated X rays. Int J Cancer 78:654-660, 1998.
59. Lawrence TS, Tepper JE, Blackstock AW: Fluoropyrimidine-radiation interactions in cells and tumors. Semin Radiat Oncol 4:260-266, 1997.
60. Levivier M, Becerra A, De Witte O, Brotchi J, Goldman S: Radiation necrosis or recurrence. J Neurosurg 84:148-149, 1996.
61. Levivier M, Goldman S, Bidaut LM, Luxen A, Stanus E, Przedborski S, Balériaux D, Hildebrand J, Brotchi J: Positron emission tomography-guided stereotactic brain biopsy. Neurosurgery 31:792-797, 1992.
62. Levivier M, Goldman S, Pirotte B, Brucher JM, Balériaux D, Luxen A, Hildebrand J, Brotchi J: Diagnostic yield of stereotactic brain biopsy guided by positron emission tomography with [18F]fluorodeoxyglucose. J Neurosurg 82:445-452, 1995.
63. Levivier M, Massager N, Wikler D, Lorenzoni J, Ruiz S, Devriendt D, David P, Desmedt F, Simon S, Van Houtte P, Brotchi J, Goldman S: Use of stereotactic PET images in dosimetry planning of radiosurgery for brain tumors: Clinical experience and proposed classification. J Nucl Med 45:1146-1154, 2004.
64. Levivier M, Wikler D, Massager N, David P, Devriendt D, Lorenzoni J, Pirotte B, Desmedt F, Simon S, Goldman S, Van Houtte P, Brotchi J: The integration of metabolic imaging in stereotactic procedures including radiosurgery: A review. J Neurosurg 97 [Suppl 5]:542-550, 2002.
65. Lightdale CJ, Heier SK, Marcon NE, McCaughan JS, Gerdes H, Overholt BF, Sivak MV, Stiegmann GV, Nava HR: Photodynamic therapy with porfimer sodium versus thermal ablation therapy with Nd:YAG laser for palliation of esophageal cancer: Amulticenter trial. Gastrointest Endosc 42:507-512, 1995.
66. Lindvall P, Bergström P, Löfroth PO, Hariz M, Henriksson R, Jonasson P, Bergenheim AT: Hypofractionated conformal stereotactic radiotherapy for arteriovenous malformations. Neurosurgery 53:1036-1043, 2003.
67. Liu L, Bassano DA, Prasad SC, Hahn SS, Chung CT: The linear-quadratic model and fractionated stereotactic radiotherapy. Int J Radiat Oncol Biol Phys 57:827-832, 2003.
68. Manning MA, Cardinale RM, Benedict SH, Kavanagh BD, Zwicker RD, Amir C, Broaddus WC: Hypofractionated stereotactic radiotherapy as an alternative to radiosurgery for the treatment of patients with brain metastases. Int J Radiat Oncol Biol Phys 47:603-608, 2000.
69. Mason KA: Radiation interactions with taxanes, old and new. Radiat Res 163:705-706, 2005.
70. Mason TJ: A sound investment. Chem Ind Nov:878-882, 1998.
71. McDannold N, Vykhodtseva N, Hynynen K: Targeted disruption of the blood-brain barrier with focused ultrasound: Association with cavitation activity. Phys Med Biol 51:793-807, 2006.
72. McGinn CJ, Shewach DS, Lawrence TS: Radiosensitizing nucleosides. J Natl Cancer Inst 88:1193-1203, 1996.
73. McNeil SE: Nanotechnology for the biologist. J Leukoc Biol 78:585-594, 2005.
74. Medintz IL, Uyeda HT, Goldman ER, Mattoussi H: Quantum dot bioconjugates for imaging, labeling, sensing. Nat Mater 4:435-446, 2005.
75. Milker-Zabel S, Zabel-Du Bois A, Henze M, Huber P, Schulz-Ertner D, Hoess A, Haberkorn U, Debus J: Improved target volume definition for fractionated stereotactic radiotherapy in patients with intracranial meningiomas by correlation of CT, MRI and [68Ga]-DOTATOC-PET. Int J Radiat Oncol Biol Phys 65:222-227, 2006.
76. Milker-Zabel S, Zabel-du Bois A, Huber P, Schlegel W, Debus J: Fractionated stereotactic radiation therapy in the management of benign cavernous sinus meningiomas. Long term experience and review of the literature. Strahlenther Onkol 182:635-640, 2006.
77. Minniti G, Saran F, Traish D, Soomal R, Sardell S, Gonsalves A, Ashley S, Warrington J, Burke K, Mosleh-Shirazi A, Brada M: Fractionated stereotactic conformal radiotherapy following conservative surgery in the control of craniopharyngiomas. Radiother Oncol 82:90-95, 2007.
78. Miwa M, Ura M, Nishida M, Sawada N, Ishikawa T, Mori K, Shimma N, Umeda I, Ishitsuka H: Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue. Eur J Cancer 34:1274-1281, 1998.
79. Mogard J, Kihlström L, Ericson K, Karlsson B, Guo WY, Stone-Elander S: Recurrent tumor vs radiation effects after gamma knife radiosurgery of intracerebral metastases: Diagnosis with PET-FDG. J Comput Assist Tomogr 18:177-181, 1994.
80. Moghimi SM, Hunter AC, Murray JC: Nanomedicine: Current status and future prospects. FASEB J 19:311-330, 2005.
81. Moghissi K, Dixon K, Parson RJ: A controlled trial of Nd-YAG laser vs photodynamic therapy for advanced malignant bronchial obstruction. Lasers Med Sci 8:269-273, 1993.
82. Mori Y, Kondziolka D, Flickinger JC, Kirkwood JM, Agarwala S, Lunsford LD: Stereotactic radiosurgery for cerebral metastatic melanoma: Factors affecting local disease control and survival. Int J Radiat Oncol Biol Phys 42:581-589, 1998.
83. Moriwaki SI, Misawa J, Yoshinari Y, Yamada I, Takigawa M, Tokura Y: Analysis of photosensitivity in Japanese cancer-bearing patients receiving photodynamic therapy with porfimer sodium (Photofrin). Photodermatol Photoimmunol Photomed 17:241-243, 2001.
84. Muller PJ, Wilson BC: Photodynamic therapy of brain tumors - a work in progress. Lasers Surg Med 38:384-389, 2006.
85. Noske DP, Wolbers JG, Sterenborg HJ: Photodynamic therapy of malignant glioma. A review of literature. Clin Neurol Neurosurg 93:293-307, 1991.
86. Nyberg G, Bergström M, Enblad P, Lilja A, Muhr C, Långström B: PETmethionine of skull base neuromas and meningiomas. Acta Otolaryngol 117:482-489, 1997.
87. Ogawa T, Shishido F, Kanno I, Inugami A, Fujita H, Murakami M, Shimosegawa E, Ito H, Hatazawa J, Okudera T, Yemura K, Yasui N, Mineura K: Cerebral glioma: Evaluation with methionine PET. Radiology 186:45-53, 1993.
88. O'Shea PG, Freund HP: Free-electron lasers: Status and applications. Science 292:1853-1858, 2001.
89. Perez OD, Nolan G, Magda D, Miller RA, Herzenberg LA, Herzenberg LA: Motexafin gadolinium (Gd-Tex) selectively induces apoptosis in HIV-1 infected CD4+ T helper cells. Proc Natl Acad Sci U S A 99:2270-2274, 2002
90. Pernot M, Aubry JF, Tanter M, Thomas JL, Fink M: High power transcranial beam steering for ultrasonic brain therapy. Phys Med Biol 48: 2577-2589, 2003.
91. Pham CJ, Chang SD, Gibbs IC, Jones P, Heilbrun MP, Adler JR Jr: Preliminary visual field preservation after staged CyberKnife radiosurgery for perioptic lesions. Neurosurgery 54:799-812, 2004.
92. Pissuwan D, Valenzuela SM, Cortie MB: Therapeutic possibilities of plasmonically heated gold nanoparticles. Trends Biotechnol 24:62-67, 2006.
93. Pitsillides CM, Joe EK, Wei X, Anderson RR, Lin CP: Selective cell targeting with light-absorbing microparticles and nanoparticles. Biophys J 84: 4023-4032, 2003.
94. Plunkett W, Gandhi V, Huang P, Robertson LE, Yang LY, Gregoire V, Estey E, Keating MJ: Fludarabine: Pharmacokinetics, mechanisms of action, and rationales for combination therapies. Semin Oncol 20 [Suppl 7]:2-12, 1993.
95. Schmieder AH, Winter PM, Caruthers SD, Harris TD, Williams TA, Allen JS, Lacy EK, Zhang H, Scott MJ, Hu G, Robertson JD, Wickline SA, Lanza GM: Molecular MR imaging of melanoma angiogenesis with alphanubeta3-targeted paramagnetic nanoparticles. Magn Reson Med 53:621-627, 2005.
96. Shaw E, Scott C, Suh J, Kadish S, Stea B, Hackman J, Pearlman A, Murray K, Gaspar L, Mehta M, Curran W, Gerber M: RSR13 plus cranial radiation therapy in patients with brain metastases: Comparison with Radiation Therapy Oncology Group Recursive Partitioning Analysis Brain Metastases Database. J Clin Oncol 21:2364-2371, 2003.
97. Shiau CY, Sneed PK, Shu HK, Lamborn KR, McDermott MW, Chang S, Nowak P, Petti PL, Smith V, Verhey LJ, Ho M, Park E, Wara WM, Gutin PH, Larson DA: Radiosurgery for brain metastases: Relationship of dose and pattern of enhancement to local control. Int J Radiat Oncol Biol Phys 37:375-383, 1997.
98. Sinclair WK: Hydroxyurea revisited: A decade of clinical effects studies. Int J Radiat Oncol Biol Phys 7:631-637, 1981.
99. Sipkins DA, Cheresh DA, Kazemi MR, Nevin LM, Bednarski MD, Li KC: Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging. Nat Med 4:623-626, 1998.
100. Skirtach AG, Antipov AA, Shchukin DG, Sukhorukov GB: Remote activation of capsules containing Ag nanoparticles and IR dye by laser light. Langmuir 20:6988-6992, 2004.
101. Slatkin DN, Spanne P, Dilmanian FA, Gebbers JO, Laissue JA: Subacute neuropathological effects of microplanar beams of x-rays from a synchrotron wiggler. Proc Natl Acad Sci U S A 92:8783-8787, 1995.
102. Sorenson CM, Barry MA, Eastman A: Analysis of events associated with cell cycle arrest at G2 phase and cell death induced by cisplatin. J Natl Cancer Inst 82:749-755, 1990.
103. Thomas JL, Fink M: Ultrasonic beam focusing through tissue inhomogeneities with a time reversal mirror: Application to transskull therapy. IEEE Trans Ultrason Ferroelectr Freq Control 43:1122-1129, 1996.
104. Triesscheijn M, Baas P, Schellens JH, Stewart FA: Photodynamic therapy in oncology. Oncologist 11:1034-1044, 2006.
105. Varallyay P, Nesbit G, Muldoon LL, Nixon RR, Delashaw J, Cohen JI, Petrillo A, Rink D, Neuwelt EA: Comparison of two superparamagnetic viral-sized iron oxide particles ferumoxides and ferumoxtran-10 with a gadolinium chelate in imaging intracranial tumors. AJNR Am J Neuroradiol 23:510-519, 2002.
106. Veiseh O, Sun C, Gunn J, Kohler N, Gabikian P, Lee D, Bhattarai N, Ellenbogen R, Sze R, Hallahan A, Olson J, Zhang M: Optical and MRI multifunctional nanoprobe for targeting gliomas. Nano Lett 5:1003-1008, 2005.
107. Whitesides GM: Nanoscience, nanotechnology, and chemistry. Small 1:172-179, 2005.
108. Willett CG, Boucher Y, di Tomaso E, Duda DG, Munn LL, Tong RT, Chung DC, Sahani DV, Kalva SP, Kozin SV, Mino M, Cohen KS, Scadden DT, Hartford AC, Fischman AJ, Clark JW, Ryan DP, Zhu AX, Blaszkowsky LS, Chen HX, Shellito PC, Lauwers GY, Jain RK: Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer. Nat Med 10:145-147, 2004.
109. Wilson BD, Mang TS, Stoll H, Jones C, Cooper M, Dougherty TJ: Photodynamic therapy for the treatment of basal cell carcinoma. Arch Dermatol 128:1597-1601, 1992.
110. Winter PM, Caruthers SD, Kassner A, Harris TD, Chinen LK, Allen JS, Lacy EK, Zhang H, Robertson JD, Wickline SA, Lanza GM: Molecular imaging of angiogenesis in nascent Vx-2 rabbit tumors using a novel alpha(nu)beta3-targeted nanoparticle and 1.5 tesla magnetic resonance imaging. Cancer Res 63:5838-5843, 2003.
111. Xu S, Zakian K, Thaler H, Matei C, Alfieri A, Chen Y, Koutcher JA: Effects of motexafin gadolinium on tumor metabolism and radiation sensitivity. Int J Radiat Oncol Biol Phys 49:1381-1390, 2001.
112. Yan H, Yin FF, Kim JH: A phantom study on the positioning accuracy of the Novalis Body system. Med Phys 30:3052-3060, 2003.